3 Results for "

DT2216

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "DT2216" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-130604
CAS No.: 2365172-42-3
Purity:  99.61%
Research Areas:  

Inflammation/Immunology Cancer

DT2216 is a potent and selective BCL-XL (Bcl-2 family member) degrader based on PROTAC technology. DT2216 causes effective degradation of BCL-XL protein by recruiting Von Hippel-Lindau (VHL) E3 ubiquitin ligase. DT2216 inhibits various BCL-XL-dependent leukemia and cancer cells but considerably less toxic to platelets .
loading...
    loading...
Cat. No.: HY-44432
CAS No.: 2143096-93-7
Synonyms: ABT-263-piperazine
Navitoclax-piperazine (ABT-263-piperazine) is a Navitoclax (HY-10087) analog and BCL-XL inhibitor. Navitoclax-piperazine is the ligand for target protein of PROTAC DT2216 (HY-130604). Navitodax-pperaie and E3 ubiquitin ligase VHL ligand can be used to synthesize PROTAC DT2216 (HY-130604) .
loading...
    loading...
Cat. No.: HY-130849
CAS No.: 2229976-21-8
Purity:  96.87%
Research Areas:  

Cancer

(S,R,S)-AHPC-Me-C5-COOH is a synthesized E3 ligase ligand-linker conjugate that incorporates the a VHL ligand and a linker. (S,R,S)-AHPC-Me-C5-COOH can be used in PROTAC DT2216 (HY-130604) .
loading...
    loading...